VMP 42034211000001106

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Co-beneldopa 12.5mg/50mg capsules
BNF code 0409010K0AAAIAI
Virtual Therapeutic Moiety Co-beneldopa
Date identifier became valid 7 Jul 2023
Previous product identifier 323107008
Basis of preferred name BAN - British Approved Name
Date of name applicability 4 May 2004
Previous name Co-beneldopa 12.5/50 capsules
Basis of previous name BAN - British Approved Name
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units capsule
Unit dose unit of measure capsule
Virtual Product Ingredient
Ingredient Benserazide hydrochloride
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 391821005
Strength value numerator 12.500
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Levodopa
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 50.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route capsule.oral
Dose Form
Formulation Oral capsule
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Co-beneldopa 12.5mg/50mg capsules (A A H Pharmaceuticals Ltd)
Co-beneldopa 12.5mg/50mg capsules (Alliance Healthcare (Distribution) Ltd)
Co-beneldopa 12.5mg/50mg capsules (Medihealth (Northern) Ltd)
Co-beneldopa 12.5mg/50mg capsules (Teva UK Ltd)
Madopar 50mg/12.5mg capsules (Roche Products Ltd)
Virtual Medicinal Product Packs
Co-beneldopa 12.5mg/50mg capsules 100 capsule
Co-beneldopa 12.5mg/50mg capsules 60 capsule

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback